Vasculitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You need to be having your first-ever diagnostic biopsy (a small tissue sample taken from the kidney) on your own natural kidney
- You must be between 18 and 90 years old
- You must be covered by French health insurance
- You must have agreed and given your consent to take part
For one specific group in the trial (ANCA vasculitis group):
- You have been diagnosed with a condition called ANCA vasculitis (inflammation of blood vessels affecting the kidney), confirmed by a kidney biopsy and a specific blood test (confirm with trial site)
For the other groups in the trial (control groups), your kidney biopsy must show one of the following diagnoses:
- Inflammation of the kidney tissue (Interstitial Nephritis)
- A kidney filtering problem with minimal visible damage (Minimal Change Nephropathy)
- A specific form of kidney scarring (Collapsing Segmental Hyalinosis)
- A kidney condition affecting the outer layer of filtering units (Extramembranous Glomerulopathy)
- A kidney condition involving a protein called IgA building up in the kidney (IgA Nephropathy)
- Kidney disease caused by diabetes (Diabetic Nephropathy)
Who may not be able to join:
- You have received a kidney transplant
- You are currently on dialysis (either haemodialysis or peritoneal dialysis)
- You are under a legal protection order, guardianship, or curatorship
- You are pregnant or breastfeeding
- You are already taking part in another interventional clinical trial, unless that trial is specifically about ANCA vasculitis or IgA nephropathy
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marine LIVROZET, Assistance Publique - Hôpitaux de Paris
Phone: +33 1 44 84 17 89
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Spatial lipidomics for measuring tubular dysmetabolism; Co-staining for measuring tubular segments markers; Immunofluorescence (at the protein level) for measuring peroxisome Proliferator-Activated Receptor-Gamma (PPAR-gamma); Spatial transcriptomics (at the mRNA level) for measuring peroxisome Proliferator-Activated Receptor-Gamma (PPAR-gamma)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.